Overview
Total raised
$4.6M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 3, 2022 | N-Zyme takes aim at reflux | An estimated 20% of Americans suffer from laryngopharyngeal reflux (LPR), and as our diets and activity levels change, those numbers continue to increase. The condition causes gastric juices to travel from the stomach, through the esophagus... |
| N-Zyme Biomedical Inc. | “A safe, effective and efficient treatment for Laryngopharyngeal Reflux” |
Reviews 0
FAQ about N-Zyme Biomedical
How much funding has N-Zyme Biomedical raised?
N-Zyme Biomedical has raised $4.6M in total across 1 funding round.
What has the press written about N-Zyme Biomedical?
Parsers VC has collected 3 articles mentioning N-Zyme Biomedical, among them “N-Zyme takes aim at reflux” (Aug 3, 2022) and “N-Zyme Biomedical Inc.”.
Is N-Zyme Biomedical still active?
Yes, N-Zyme Biomedical is active; its latest activity on Parsers VC dates from Jul 22, 2026.